PARP7 抑制I型干扰素信号传递,以预防自身免疫和肺部疾病
Devon Jeltema1, Kennady Knox1, Nicole Dobbs1
1Department of Immunology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
The Journal of experimental medicine
|February 19, 2025
概括
聚 ((ADP-ribose) 聚合酶7 (PARP7) 对I型干扰素 (IFN-I) 的产生产生产生负面调节. 在小鼠中失去PARP7会导致系统性自身免疫和肺炎,突出其在免疫恒温中的作用.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- I型干扰素 (IFN-I) 对于抗病毒反应至关重要,但需要严格监管.
- 干扰素刺激基因 (ISG) 包括抗病毒效应体和负反调节体.
- 在IFN-I调节中,多基酶 (PARP) 家族在IFN-I调节中的作用在很大程度上是未被探索的.
研究的目的:
- 研究PARP家族成员在调节IFN-I生产中的作用.
- 描述PARP7作为IFN-I信号的负调节器的功能.
- 阐明PARP7控制先天性免疫反应并维持免疫平衡的机制.
主要方法:
- 对16名PARP家族成员进行IFN-I监管活动的选.
- 使用Parp7淘汰赛 (Parp7-/-) 和催化不活性 (Parp7H532A/H532A) 的小鼠模型.
- 研究PARP7与IRF3和转录复合体相互作用的分子机制.
- 在小鼠模型中分析免疫细胞透,自身抗体产生和细胞因子水平.
- 使用Irf3和Sting缺陷小鼠进行遗传救援实验.
主要成果:
- 16个PARP中的11个被确定为ISG,其中8个抑制IFN-I生产.
- PARP7成为IFN-I生产中最强大的负调节器.
- 失去PARP7导致了系统性自身免疫,脊髓巨变,自身抗体和炎症性细胞因子的升高.
- PARP7 缺乏导致免疫透和肺中的三级淋巴体结构.
- PARP7通过MARylation抑制先天免疫,破坏IFN-I生产所需的IRF3:CBP/p300复合体.
- Irf3或Sting缺陷拯救了Parp7损失引起的自身免疫和肺病理.
结论:
- PARP7是IFN-I生产的关键生理负反调节器.
- PARP7在维持免疫平衡中起着至关重要的作用,特别是在肺部.
- 对PARP7的失调有助于自身免疫病原和炎症性肺病.
相关概念视频
Experimental RNAi
6.0K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.0K
The JAK-STAT Signaling Pathway
8.6K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.6K
piRNA - Piwi-interacting RNAs
6.8K
PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
6.8K
RNA Interference
25.9K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
25.9K
Regulation of the Unfolded Protein Response
2.4K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K


